Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.04
+0.09 (0.43%)
At close: Mar 6, 2026, 4:00 PM EST
21.05
+0.01 (0.05%)
After-hours: Mar 6, 2026, 7:51 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 6.94M | 9.04M | 14.02M | - | - | | | |
Biotechnology (Startups) Growth | -23.23% | -35.50% | - | - | - | | | |
| 6.94M | 9.04M | 14.02M | - | - | | | |
| -23.23% | -35.50% | - | - | - | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 6.94M | 9.04M | 14.02M | - | - | | | |
| -23.23% | -35.50% | - | - | - | | | |
| 6.94M | 9.04M | 14.02M | - | - | | | |
| -23.23% | -35.50% | - | - | - | | | |
Source: S&P Global Market Intelligence.
